Measuring disease activity and damage in discoid lupus erythematosus

British Journal of Dermatology

Volumn 162, Issue 5, 2010, Pages 1030-1037

  Wahie, S ^a   McColl, E ^a   Reynolds, N J ^a   Meggitt, S J ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Discoid lupus erythematosus; Disease severity; Reliability; Scoring instrument; Validation

Indexed keywords

ARTICLE; CLINICAL ARTICLE; DISCOID LUPUS ERYTHEMATOSUS; DISEASE ACTIVITY; DISEASE SEVERITY; ERYTHEMA; HUMAN; INTERRATER RELIABILITY; PEER REVIEW; PIGMENT DISORDER; PRIORITY JOURNAL; QUALITY OF LIFE; SCAR FORMATION; SCORING SYSTEM; SKIN ATROPHY; SKIN INDURATION;

ATTITUDE OF HEALTH PERSONNEL; FEEDBACK; HUMANS; LUPUS ERYTHEMATOSUS, DISCOID; OBSERVER VARIATION; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 77951227850     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09656.x     Document Type: Article

References (24)

1. de Berker D, Dissaneyeka M, Burge S. The sequelae of chronic cutaneous lupus erythematosus. Lupus 1992 3 : 181 186.
2. Parodi A, Massone C, Cacciapuoti M et al. Measuring the activity of disease in patients with cutaneous lupus erythematosus. Br J Dermatol 2000 142 : 457 460. (Pubitemid 30159067)
3. Goodfield M. Measuring the activity of disease in cutaneous lupus erythematosus. Br J Dermatol 2000 142 : 397 400. (Pubitemid 30159059)
4. Jessop S, Whitelaw D, Jordaan F. Drugs for discoid lupus. Cochrane Database Syst Rev 2001 1 : CD002954.
5. Ruzicka T, Sommerburg C, Goerz G et al. Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine. Br J Dermatol 1992 127 : 513 518.
6. Berth-Jones J. The SASSAD (Six Area Six Sign Atopic Dermatitis Severity Score): a simple system for monitoring disease activity in atopic dermatitis. Br J Dermatol 1996 135 (Suppl. 48 25 30. (Pubitemid 126833475)
7. Schmitt J, Wozel G. The Psoriasis Area and Severity Index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology 2005 210 : 194 199. (Pubitemid 40529233)
8. Severity scoring of atopic dermatitis: the SCORAD index. Consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1993 186 : 23 31.
9. Finlay AY. Measurement of disease activity and outcome in atopic dermatitis. Br J Dermatol 1996 135 : 509 515. (Pubitemid 26340258)
10. Albrecht J, Werth VP. Development of the CLASI as an outcome instrument for cutaneous lupus erythematosus. Dermatol Ther 2007 20 : 93 101. (Pubitemid 46817424)
11. Albrecht J, Taylor L, Berlin JA et al. The CLASI (Cutaneous Lupus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus. J Invest Dermatol 2005 125 : 889 894.
12. Abdel-Aziz K, Goodfield M. Evaluation of the Cutaneous Lupus Activity and Severity Score in the assessment of lupus erythematosus skin disease. Br J Dermatol 2008 158 : 181 182. (Pubitemid 350221907)
13. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994 19 : 210 216.
14. Charman C. Reliability testing of the SASSAD score. Br J Dermatol 2002 146 : 1057 1060.
15. Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to their Development and Use, 2nd edn.
16. Berth-Jones J, Thompson J, Papp K Copenhagen Psoriasis Working Group. A study examining inter-rater and intrarater reliability of a novel instrument for assessment of psoriasis: the Copenhagen Psoriasis Severity Index. Br J Dermatol 2008 159 : 407 412. (Pubitemid 352009865)
17. Hongbo Y, Thomas CL, Harrison MA et al. Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Invest Dermatol 2005 125 : 659 664.
18. Kyriakis KP, Michailides C, Palamara I et al. Lifetime prevalence distribution of chronic discoid lupus erythematosus. J Eur Acad Derm Venerol 2007 21 : 1105 1147.
19. Tebbe B, Orfanos CE. Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus 1997 6 : 96 104. (Pubitemid 27102036)
20. Meller S, Homey B, Ruzicka T. Socioeconomic factors in lupus erythematosus. Autoimmun Rev 2005 4 : 242 246. (Pubitemid 40704710)
21. Charman C, Chambers C, Williams H. Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring? J Invest Dermatol 2003 120 : 932 941. (Pubitemid 36702900)
22. Charman C, Williams H. Outcome measures of disease severity in atopic eczema. Arch Dermatol 2000 136 : 763 769. (Pubitemid 30407434)
23. Cohen J. Statistical Power Analysis for the Behavioral Sciences, 2nd edn.
24. Linnet J, Jemec GB. An assessment of anxiety and dermatology life quality in patients with atopic dermatitis. Br J Dermatol 1999 140 : 268 272. (Pubitemid 29111355)